|Day Low/High||49.54 / 50.52|
|52 Wk Low/High||42.40 / 66.04|
Analysts say nation will turn a new leaf, changing federal law within a few years, as cannabis industry expected to grow big time over next decade.
It all comes down to matching my time frame.
Canopy's earnings losses could just be a stepping stone to becoming the industry leader.
As we have seen so far, in terms of market reaction, there is great reward at the point of sale in beating expectations.
CGC has the best chance to transition to broader success should the U.S. ever go the route of legalization beyond the state level.
Not to be outcome by a unicorn company, the unicorn sector of the markets, cannabis, is unleashing a blitzkrieg of news this morning. On the acquisition side, Cresco Labs is buying Origin House (CannaRoyalty) this morning for a small premium. It app...
While the two tobacco giants have similar yields, both also have very different businesses, with different growth potential in the years ahead.
Revenue is where it's at for cannabis in 2019.
A huge week is coming up for these well-known stocks.
Investors can gain exposure to the high-flying cannabis industry without taking on undue risks.
The move was helped by the TLRY's deals with AB InBev for beverages and Novartis for medical applications.
In this day and age, companies must be 'disruptors' or get left in the dust.
I know that Nelson is fascinated by the medicinal properties chiefly as a replacement for opioids, the scourge of this country.
Aurora's prominent partner could be cannabis' key to breaking into consumer segments.
With shares breaking above the recent, albeit small, pennant, there might be reason for optimism.
GSKY bulls watched as the stock lost two-thirds of its value from its post-IPO high and are now looking for news to turn the bearish tide.
And why I won't recommend any other stocks in these markets, right now.
Examining the influential short-sellers' big winners and losers provides important insights into trading and investing.
These stocks have grown their dividend for years but the yield has now reached levels of attraction.
Many see the Fed as done for the year. Never assume. Read the words as they are written.
Before I bid everyone here at the Diary good day and plug into the earnings reports and corresponding conference calls I listed in my last post, here are some of the reports hitting the tape Thursday morning that I'll be watching and things I'll be ...
Altria's recent selloff should be welcomed by both value seekers and those desiring quarterly income to live on.
Any logical evaluation of this stock suggests low risk and tremendous upside.
Any logical evaluation of British American Tobacco suggests low risk and tremendous upside.
Canopy Growth's smoking engine won't necessarily ensure smooth sailing for Constellation.
What matters here is the ability to innovate, market, and sell.
Establishing who the stragglers are and what impact they might have in the future is the key at this point.